4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-030961
Chief Financial Officer sold 57,766 shares at an average $89.12 ($5,148,024)
- Chief Financial Officer acquired 47,890 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bonstein Sara · Chief Financial Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +24,150 | $18.95 | $457,643 | 137,438 | D |
| 2025-06-10 | Exercise or conversion : show line 2 in the form 10b5-1 | +23,740 | $17.07 | $405,242 | 161,178 | D |
| 2025-06-10 | Sale : show line 3 in the form 10b5-1 | −7,277 | $87.12 | $633,972 | 153,901 | D |
| 2025-06-10 | Sale : show line 4 in the form 10b5-1 | −7,310 | $88.29 | $645,400 | 146,591 | D |
| 2025-06-10 | Sale : show line 5 in the form 10b5-1 | −20,926 | $88.99 | $1,862,205 | 125,665 | D |
| 2025-06-10 | Sale : show line 6 in the form 10b5-1 | −15,825 | $89.85 | $1,421,876 | 109,840 | D |
| 2025-06-10 | Sale : show line 7 in the form 10b5-1 | −6,328 | $90.93 | $575,405 | 103,512 | D |
| 2025-06-10 | Sale : show line 8 in the form 10b5-1 | −100 | $91.66 | $9,166 | 103,412 | D |
| Open-market sales · 57,766 sh · avg $89.12 · $5,148,024 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-10 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −24,150 | 134,260 | D |
| 2025-06-10 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) | −23,740 | 35,610 | D |
Loading xslF345X05/wk-form4_1749759395.xml…